Benzinga | Nov 10, 2020 04:06PM EST

Pulmonx Q3 EPS $(1.37) Beats $(4.32) Estimate, Sales $10.60M Beat $8.37M Estimate

Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(1.37) per share which beat the analyst consensus estimate of $(4.32) by 68.29 percent. The company reported quarterly sales of $10.60 million which beat the analyst consensus estimate of $8.37 million by 26.64 percent.